Part of the Clinical Focus series, this book is a comprehensive guide to the diagnosis and treatment of tuberculosis. The new volume is highly illustrated with tables and images and written by an internationally recognised editor and author team.

This work contains updated and clinically relevant information about tuberculosis. It is aimed at providing a succinct overview of history and disease epidemiology, clinical presentation and the most recent scientific developments in the field of tuberculosis research, with an emphasis on diagnosis and treatment. It may serve as a practical resource for students, clinicians and researchers who work in the field of infectious diseases.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Completely updated and revised, Clinical Tuberculosis continues to provide the TB practitioner-whether in public health, laboratory science or clinical practice-with a synoptic and definitive account of the latest methods of diagnosis, treatment and control of this challenging and debilitating disease.New in the Fifth Edition:Gamma interferon-based

Hypersensitivity pneumonitis, also known as extrinsic allergic alveolitis, is an inflammation of the lungs due to breathing in a foreign substance, usually certain types of dust, fungus, or moulds. Part of the Clinical Focus Series, Hypersensitivity Pneumonitis is a concise guide to the condition, discussing epidemiologic, immune-pathologic, physiologic, diagnostic and therapeutic developments. The text also examines genetics, lung function, bronchoscopy, treatment and new findings in the field. Written by an author and editor team from the USA, Europe and Asia, each chapter is enhanced with tables and illustrations, as well as X-Rays and CT images. Key Features Concise guide to hypersensitivity pneumonitis (extrinsic allergic alveolitis) Discusses epidemiology, immune-pathology, physiology, diagnosis and treatment Includes chapter on new findings in the field Experienced author and editor team from the USA, Europe and Asia Numerous tables, illustrations, X-Rays and CT images

This book is a comprehensive assessment of the patients with COPD and asthma with appropriate diagnosis and management. Review on the diagnosis and management of the patients with bronchiectasis and cystic fibrosing along with the current management of acute exacerbation. A discussion of the diagnosis and management of the patients with idiopthic pulmonary fibrosis and an acute exacerbation and the management options those are currently available. Extensive reviews of the treatment of acute pulmonary exacerbation of sarcoidosis and the three phases of hypersensitivity pneumonitis (acute, subac.

Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis: The Essentials scrutinizes the new discoveries and observations of the key aspects of the disease. Recognized world experts provide a concise, state-of-the-art review of the 15 essential elements of TBsupply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methodsdiscuss the emerging threat of XDR-TB and the HIV/AIDS factorassess advances in TB research such as new drugs and vaccinesreflect on the progress of the "Stop TB" strategy.